Oppenheimer Maintains Outperform on HCA Healthcare, Raises Price Target to $315
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Michael Wiederhorn has maintained an Outperform rating on HCA Healthcare (NYSE:HCA) and raised the price target from $310 to $315.
July 28, 2023 | 1:39 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HCA Healthcare's price target has been raised by Oppenheimer from $310 to $315, maintaining an Outperform rating.
The raised price target and maintained Outperform rating by Oppenheimer indicates a positive outlook for HCA Healthcare. This could potentially attract more investors, driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100